Smoking Cessation Program for Inpatients with Substance Use Disorder: A Quasi-Randomized Controlled Trial of Feasibility and Efficacy

Conclusion: A smoking cessation/reduction program is feasible for substance-dependent in-patients undergoing detoxification. Although the RSP appears to be effective in terms of harm reduction in in-patients with SUD, more cost- and time-efficient programs might also be suitable for this population.Eur Addict Res 2016;22:268-276
Source: European Addiction Research - Category: Addiction Source Type: research

Related Links:

CONCLUSIONS: There is high-certainty evidence that bupropion can aid long-term smoking cessation. However, bupropion also increases the number of adverse events, including psychiatric AEs, and there is high-certainty evidence that people taking bupropion are more likely to discontinue treatment compared with placebo. However, there is no clear evidence to suggest whether people taking bupropion experience more or fewer SAEs than those taking placebo (moderate certainty). Nortriptyline also appears to have a beneficial effect on smoking quit rates relative to placebo. Evidence suggests that bupropion may be as successful as...
Source: Cochrane Database of Systematic Reviews - Category: General Medicine Authors: Tags: Cochrane Database Syst Rev Source Type: research
ConclusionsOur PBPK/PD model may be helpful in further investigations of nicotine dependence and smoking cessation strategies. As the model represents the first nicotine PBPK/PD  model predicting nicotine concentration and heart rate profiles after the use of e-cigarettes, it could also contribute to a better understanding of the recent increase in youth e-cigarette use.
Source: Clinical Pharmacokinetics - Category: Drugs & Pharmacology Source Type: research
(Society for the Study of Addiction) A real-world study of over 600,000 adult participants without a history of depression has found that the stop-smoking medication varenicline (marketed as Chantix and Champix) does not appear to be associated with an increased risk of cardiovascular or neuropsychiatric hospitalization compared with nicotine replacement therapy (NRT). These findings confirm those of earlier clinical trials, providing further evidence of the safety of varenicline as an aid to stop smoking.
Source: EurekAlert! - Social and Behavioral Science - Category: International Medicine & Public Health Source Type: news
Conclusion: The results reflect the participants' perspective on what is meaningful to them when trying to quit smoking and adds important knowledge to future smoking cessation studies in this patient group. PMID: 32046611 [PubMed - in process]
Source: International Journal of Qualitative Studies on Health and Well-being - Category: International Medicine & Public Health Tags: Int J Qual Stud Health Well-being Source Type: research
Results from this study recently published online in Addiction found primary care physicians providing smokers with a free, two week starter kit of nicotine replacement therapy (NRT) increased quit attempts While sitting in the dentist's office, Hollings Cancer Center researcher Matthew Carpenter, Ph.D., of the Medical University of South Carolina, had a bright idea. As he received his goody bag with dental hygiene products, he wondered why not conduct a study and have primary care providers do the same thing for their patients who use tobacco. The bags would contain educational material, free lozenges and tobacco cessati...
Source: Dental Technology Blog - Category: Dentistry Source Type: news
(Medical University of South Carolina) Results from this study, recently published online in Addiction, found providing smokers with a free, two week starter kit of nicotine replacement therapy (NRT) increased quit attempts, use of stop smoking medications, and smoking abstinence as compared with standard care in a primary care setting.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news
There are more than 50 Cochrane Reviews of the effects of interventions to help people quit smoking; one of which investigates whether reducing smoking before quitting might be an alternative to stopping suddenly. It was updated in September 2019 and we asked lead author, Nicola Lindson, from the Cochrane Tobacco Addiction Group based in the University of Oxford in the UK to tell us about their latest findings.The standard way that people are told to quit smoking is to smoke as normal until a quit day, and then stop using all cigarettes. However, this is daunting for many, and those who have tried it without success might ...
Source: Cochrane News and Events - Category: Information Technology Authors: Source Type: news
Conclusions: The follow-up after discharge in specialized units of tobacco cessation is very low, yet the efficacy of the treatment per year was high.
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Tags: Tobacco, smoking control and health educ. Source Type: research
E-cigarettes burst onto the scene in the 2010s and were quickly embraced by the public as a solution to the problem of smoking, even heralded by former Surgeon General Richard Carmona as having “very meaningful harm reduction potential” for adult smokers. Astonishingly, e-cigarette manufacturers were never required to demonstrate that their devices were safe, or even safer than combustible cigarettes — the idea that a product could be more health-harming than tobacco seemed so unfathomable as to be not worthy of serious consideration. Fast forward a decade and a lot has happened The e-cigarette industry c...
Source: Harvard Health Blog - Category: Consumer Health News Authors: Tags: Addiction Lung disease Smoking cessation Source Type: blogs
Condition:   Nicotine Addiction Interventions:   Drug: Cytisine;   Drug: Nicotine Replacement Therapy (NRT) Sponsors:   Loma Linda University;   Mongolian National University of Medical Sciences;   Pfizer Not yet recruiting
Source: - Category: Research Source Type: clinical trials
More News: Addiction | Nicotine | Nicotine Replacement Therapy | Smokers | Study